Measles cases in Australia continue to climb, and the latest reports from Western Australia bring the number to about 80, ...

While most people will clear the virus and get a negative antigen test result within 10 days, some people may keep testing positive for longer than that, experts tell TODAY.com. And if you keep ...

Common cold coronavirus incidence decreased by more than half after widespread SARS-CoV-2 infections and vaccination compared ...

Abbott Laboratories (NYSE:ABT) now projects organic sales growth, excluding COVID-19 testing-related sales, to grow between 7 ...

What to know about COVID symptoms, testing and incubation as the new "razor blade throat" Nimbus variant has caused a summer 2025 spike.

The ongoing tariff negotiations have created a potentially more uncertain environment for electronics and other supply chains ...

Today, as finance leaders face new threats—from AI ethics to climate risk—the hard-won lessons of this crisis remain urgent.

An experimental mRNA vaccine has boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to ...

Stocks rose Thursday as investors responded to a flurry of quarterly earnings reports from major companies and better-than-expected retail sales data.

The White House on Thursday said President Trump underwent medical testing due to “mild swelling” in his legs, unveiling a ...

Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.

Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...